Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
A Preferred Substrate-based Nomenclature in Myocardial Ischaemic Syndromes
Author(s): William E Boden , Juan Carlos Kaski , C Noel Bairey Merz , et al Added: 9 months ago

MI/ACS
Staging of Heart Failure with Preserved Ejection Fraction
Author(s): Anastasia Shchendrygina , Ilya Giverts , Mariya Tokmakova , et al Added: 1 year ago

Imaging & Diagnostics

Heart Failure
2023 ACC/AHA/ACCP/HRS Guideline on AF Diagnosis & Management
Author(s): Jose A Joglar Added: 2 years ago
Dr Jose Joglar (UT Southwestern, US) joins us virtually to discuss the 2023 guidelines for atrial fibrillation (AF) diagnosis and management.These guidelines are an update to the 2014 document covering the full spectrum of managing patients with AF, from prevention to lifetime interventions, to rhythm and rate control, as well as special populations. A new classification of AF has been created,… View more

Guidelines & Statements

Electrophysiology & Arrhythmia
2023 ESC Guidelines Update: Acute & Chronic Heart Failure
Author(s): Giuseppe Rosano , Harriette Van Spall Added: 2 years ago
ESC 23 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Giuseppe Rosano (St George’s Hospitals NHS Trust University of London, UK), President of HFA to distil the key messages from the 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Prof Rosano summarises the retained ejection fraction… View more

Guidelines & Statements

Heart Failure
ERA 25: Treating Obesity in 2025 and Beyond
Author(s): Ruben Nogueiras Added: 8 months ago
ERA 2025 - Dr Ruben Nogueiras (University of Santiago de Compostela, Santiago, ES) joins us to discuss upcoming treatments that will soon be approved for the treatment of obesity, including dual agonists that will also target type two diabetes. As well as exploring the evolution of our understanding and classification of obesity, Dr Nogueiras shares his view of obesity a multifactorial disease… View more

Cardiovascular Renal Metabolic
Renato D Lopes
Research Area(s) / Expertise: Job title: Professor of Medicine
Dr Renato D Lopes is currently the Director of Clinical Events Classification (CEC) and the Co-Director of the Integrated Clinical Events-Safety Surveillance Group. His primary research interests include investigating the impact and outcomes of atrial fibrillation complicating acute coronary syndromes. Dr Lopes completed his clinical training at the Federal University of São Paulo, and his… View more
Complex Cases: TAVI and SAVR Outcomes in Patients with Bicuspid Aortic Stenosis with Prof Ole De Backer
Author(s): Ole De Backer Added: 6 months ago
Explore the challenges and outcomes of TAVI in bicuspid aortic stenosis with Prof Ole De Backer (Rigshospitalet, Copenhagen, Denmark).This presentation, part of a comprehensive two-part series on complex cases in interventional cardiology, examines the unique anatomical considerations and clinical evidence when treating bicuspid valve disease with transcatheter techniques.Prof De Backer addresses… View more

Intervention
Definitions and Implications of Shock Diagnosis and Therapy with Dr Frederick Welt
Author(s): Frederick Welt Added: 4 months ago
Learn about the definition and implications of a shock diagnosis and systems of care and the role of the shock team from Dr Frederick Welt (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick… View more

Heart Failure

Intervention
AHA 23: The ORFAN Study
Author(s): Charalambos Antoniades Added: 2 years ago
AHA 23 — In this brief interview, we are joined by Prof Charalambos Antoniades (Oxford University, UK) to discuss the ORFAN trial, sponsored by the University of Oxford.ORFAN is a prospective, multicenter, observational study that collected CT scans, biological material and outcomes data to develop and validate biomarkers of cardiometabolic risk. The registry included 250000 unselected… View more

Digital Health

Prevention & Chronic Conditions
Research Area(s) / Expertise: Job title: Reader in Cardiovascular Physiology
Personal History Dr Jamie O'Driscoll is based in Canterbury, UK where he holds the position of Reader in Cardiovascular Physiology at Canterbury Christ Church University. Academic History Dr Jamie O'Driscoll, BSc (Hons), MSc (Hons), CertEd, PhD, graduated with a 1st class honours in Sport Science from Brunel University, where he went on to earn a distinction in his MSc in Health and… View more